Supportive Care Intervention In Patients Hospitalized For Hematopoietic Stem Cell Transplantation (Shield)

Inclusion Criteria: * Patients Eligibility Criteria: * Adult patients (≥18 years) with hematologic malignancy admitted to Massachusetts General Hospital for HSCT are eligible for the study. * Ability to speak English or able to complete questionnaires with minimal assistance required from an interpreter or family member. * Caregivers Eligibility Criteria: * Adult caregivers (\>18 years) of patients undergoing HSCT at MGH who agreed to participate in study. * A relative or a friend, identified by the patient who either lives with the patient or has in-person contact with him or her at least twice per week. * Ability to read questions in English or willing to complete questionnaires with the assistance of an interpreter. Exclusion Criteria: * Patients with prior history of HSCT. * Patients undergoing HSCT for a benign hematologic condition (myelodysplastic syndrome (MDS) is not considered a benign hematologic condition and patients with MDS are eligible for the study) * Significant uncontrolled psychiatric disorder (psychotic disorder, bipolar disorder, major depression) or other co-morbid disease (dementia, cognitive impairment), which the treating clinician believes prohibits informed consent or participation in the study. * Patients enrolled on other supportive care intervention trials.